Generic-Drug Developer Lannett Files For Bankruptcy
Wall Street Journal
Restructuring agreement with strong secured creditor support will allow the company to reduce its debt by around $597 million.
https://www.wsj.com/articles/generic-drug-developer-lannett-files-for-bankruptcy-d4c3b450